UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Osteoclast Differentiation Factor is a Ligand for Osteoprotegerin/Osteoclastogenesis-Inhibitory Factor and is Identical to TRANCE/RANKL

Proceedings of the National Academy of Sciences - PNAS, 1998-03, Vol.95 (7), p.3597-3602

1998

Volltextzugriff (PDF)

Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions

Journal of bone and mineral research, 2001-10, Vol.16 (10), p.1787-1794

2001

Volltextzugriff (PDF)

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor

Bone (New York, N.Y.), 1999-11, Vol.25 (5), p.517-523

1999

Volltextzugriff (PDF)

A novel molecular mechanism modulating osteoclast differentiation and function

Bone (New York, N.Y.), 1999-07, Vol.25 (1), p.109-113

1999

Volltextzugriff (PDF)

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

Hepatology (Baltimore, Md.), 1996-09, Vol.24 (3), p.636-642

1996

Volltextzugriff (PDF)

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

The Journal of experimental medicine, 2000-01, Vol.191 (2), p.275-286

2000

Volltextzugriff (PDF)

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

Bone (New York, N.Y.), 1998-12, Vol.23 (6), p.495-498

1998

Volltextzugriff (PDF)

RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis

Biochemical and biophysical research communications, 1998-12, Vol.253 (2), p.395-400

1998

Volltextzugriff (PDF)

Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin

Biochemical and biophysical research communications, 1998-06, Vol.247 (3), p.610-615

1998

Volltextzugriff (PDF)

Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function

Endocrinology (Philadelphia), 2000-09, Vol.141 (9), p.3478-3484

2000

Volltextzugriff (PDF)

Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with Osteoporosis

Journal of bone and mineral research, 1999-04, Vol.14 (4), p.518-527

1999

Volltextzugriff (PDF)

Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits Osteoclastogenesis

Biochemical and biophysical research communications, 1997-05, Vol.234 (1), p.137-142

1997

Volltextzugriff (PDF)

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene

The Journal of biological chemistry, 2003-06, Vol.278 (26), p.23971-23977

2003

Volltextzugriff (PDF)

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

Endocrinology (Philadelphia), 1998-03, Vol.139 (3), p.1329-1337

1998

Volltextzugriff (PDF)

A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers

Molecular and Cellular Biology, 1991-12, Vol.11 (12), p.6041-6049

1991

Volltextzugriff (PDF)

Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures

Biochemical and biophysical research communications, 1998-05, Vol.246 (1), p.199-204

1998

Volltextzugriff (PDF)

Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells

The Journal of biological chemistry, 1998-10, Vol.273 (42), p.27091-27096

1998

Volltextzugriff (PDF)

Hepatocyte Growth Factor and Its Variant with a Deletion of Five Amino Acids Are Distinguishable in Their Biological Activity and Tertiary Structure

Biochemical and biophysical research communications, 1994-04, Vol.200 (2), p.808-815

1994

Volltextzugriff (PDF)

Hepatocyte Growth Factor Induces Differentiation of Adult Rat Bone Marrow Cells into a Hepatocyte Lineage in Vitro

Biochemical and biophysical research communications, 2000-12, Vol.279 (2), p.500-504

2000

Volltextzugriff (PDF)

Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs

Biochemical and biophysical research communications, 2007-09, Vol.361 (1), p.62-67

2007

Volltextzugriff (PDF)

Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor

Experimental cell research, 1991-02, Vol.192 (2), p.574-580

1991

Volltextzugriff (PDF)

Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor

The Journal of biological chemistry, 1998-02, Vol.273 (9), p.5117-5123

1998

Volltextzugriff (PDF)

Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of Bone

Biochemical and biophysical research communications, 1998-05, Vol.246 (2), p.337-341

1998

Volltextzugriff (PDF)

Parathyroid Hormone-induced Bone Resorption Does Not Occur in the Absence of Osteopontin

The Journal of biological chemistry, 2001-04, Vol.276 (16), p.13065-13071

2001

Volltextzugriff (PDF)

Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

Journal of bone and mineral metabolism, 2002-01, Vol.20 (6), p.337-344

2002

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(142)
Tagungsberichte
(4)

Sprache

Englisch
(131)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(87)
Animals
(74)
Biological And Medical Sciences
(43)
Humans
(43)
Mice
(38)
Male
(33)
Biochemistry & Molecular Biology
(31)
Physical Sciences
(27)
Osteoprotegerin
(26)
Rats
(26)
Fundamental And Applied Biological Sciences. Psychology
(23)
Medical Sciences
(20)
Receptors, Cytoplasmic And Nuclear
(20)
Biophysics
(19)
Cells, Cultured
(19)
Receptors, Tumor Necrosis Factor
(19)
Chemistry
(16)
Rank Ligand
(16)
Receptor Activator Of Nuclear Factor-Kappa B
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Osteoclast Differentiation Factor is a Ligand for Osteoprotegerin/Osteoclastogenesis-Inhibitory Factor and is Identical to TRANCE/RANKL

Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor

A novel molecular mechanism modulating osteoclast differentiation and function

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis

Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin

Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function

Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with Osteoporosis

Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits Osteoclastogenesis

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers

Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures

Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells

Hepatocyte Growth Factor and Its Variant with a Deletion of Five Amino Acids Are Distinguishable in Their Biological Activity and Tertiary Structure

Hepatocyte Growth Factor Induces Differentiation of Adult Rat Bone Marrow Cells into a Hepatocyte Lineage in Vitro

Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs

Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor

Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor

Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of Bone

Parathyroid Hormone-induced Bone Resorption Does Not Occur in the Absence of Osteopontin

Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

Suchergebnisse filtern